SCOPUS 정보 검색 플랫폼

Psychosomatics

Volumn 42, Issue 6, 2001, Pages 477-481

Olanzapine for the treatment of psychosis in patients with Parkinson’s disease and dementia

(3) Marsh, Laura a Lyketsos, Constantine a Reich, Stephen G a

a JOHNS HOPKINS UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; DEMENTIA; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; PARANOIA; PARKINSON DISEASE; PHYSICAL CAPACITY; PSYCHOSIS; SEDATION; TREATMENT OUTCOME;

EID: 0035696459 PISSN: 00333182 EISSN: None Source Type: Journal
DOI: 10.1176/appi.psy.42.6.477 Document Type: Article

Times cited : (45)

References (26)

1
- 0027437983
- Risk factors for nursing home placement in advanced Parkinson’s disease
- (1993) Neurology , vol.43 , pp. 2227-2229
- Goetz, C.G.¹ Stebbins, G.T.²

2
- 0032916601
- Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study
- (1999) Arch Neurol , vol.56 , pp. 595-601
- Aarsland, D.¹ Larsen, J.P.² Cummings, J.L.³

3
- 0033638524
- Psychosis in Parkinson’s disease: Between a rock and a hard place
- (2000) International Review of Psychiatry , vol.12 , pp. 319-334
- Henderson, M.J.¹ Mellers, J.D.C.²

4
- 0030065502
- Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
- (1996) Neuropsychopharmacology , vol.14 , pp. 111-123
- Beasley, C.M.¹ Tollefson, G.² Tran, P.³

5
- 0033545542
- Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease
- (1999) N Engl J Med , vol.340 , pp. 757-763

6
- 0026514953
- Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases
- (1992) J Neurol Neurosurg Psychiatry , vol.55 , pp. 181-184
- Hughes, A.J.¹ Daniel, S.E.² Kilford, L.³

7
- 84870465485
- Washington, DC, American Psychiatric Association
- (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition

8
- 0019977946
- Negative vs positive schizophrenia: Definition and validation
- (1982) Arch Gen Psychiatry , vol.39 , pp. 789-794
- Andreasen, N.¹ Olsen, S.²

9
- 0030958347
- The neuropsychiatric inventory: Assessing psychopathology in dementia patients
- (1997) Neurology , vol.48 , pp. 10-16
- Cummings, J.L.¹

10
- 0000224448
- Unified Parkinson’s disease rating scale
- edited by Fahn S, Marsden CD, Goldstein M. New York, Macmillan
- Recent Developments in Parkinson’s Disease II , pp. 1987
- Fahn, S.¹ Elton, R.L.²

11
- 0016823810
- Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
- (1975) J Psychiatr Res , vol.12 , pp. 189-198
- Folstein, M.F.¹ Folstein, S.E.² McHugh, P.R.³

12
- 0003429583
- Odessa, FL: Psychological Assessment Resources
- Dementia Rating Scale (DRS) Professional Manual , pp. 1988
- Mattis, S.¹

13
- 0032752941
- Worsening of motor features of parkinsonism with olanzapine
- (1999) Mov Disord , vol.14 , pp. 1014-1016
- Molho, E.S.¹ Factor, S.A.²

14
- 0029845563
- Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease
- (1996) Neurology , vol.47 , pp. 1085-1087
- Wolters, E.C.¹ Jansen, E.N.H.² Tuynman-Qua, H.G.³

15
- 0032840961
- Olanzapine for psychosis in patients with Parkinson’s disease with and without dementia
- (1999) J Neuropsychiatry Clin Neurosci , vol.11 , pp. 392-394
- Aarsland, D.¹ Larsen, J.P.² Lim, N.G.³

16
- 0031733612
- Olanzapine in the treatment of hallucinosis in idiopathic Parkinson’s disease: A cautionary note
- (1998) J Neurol Neurosurg Psychiatry , vol.65 , pp. 774-777
- Graham, J.M.¹ Sussman, J.D.² Ford, K.S.³

17
- 85046223407
- Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease
- (1998) Neurology , vol.50 , pp. 1195-1196
- Friedman, J.¹

18
- 0031723842
- Substituting clozapine for olanzapine in psychiatrically stable Parkinson’s disease patients: Results of an open label pilot study
- (1998) Clin Neuropharmacol , vol.21 , pp. 285-288
- Friedman, J.H.¹ Goldstein, S.² Jacques, C.³

19
- 0031949643
- Olanzapine can worsen parkinsonism
- (1998) Neurology , vol.50 , pp. 1183-1184
- Jimenez-Jimenez, F.J.¹ Tallon-Barranco, A.² Orti-Pareja, M.³

20
- 0034718471
- Olanzapine and clozapine: Comparative effects on motor function in hallucinating PD patients
- (2000) Neurology , vol.55 , pp. 789-794
- Goetz, C.G.¹ Blasucci, L.M.² Leurgans, S.³

21
- 0002643609
- Assessment of Parkinson’s disease
- edited by Munsat TL. Boston, Butterworth
- Quantification of Neurologic Deficit , pp. 1989
- Lang, A.E.¹ Fahn, S.²

22
- 2042526185
- Olanzapine binding to dopamine receptors in vitro and in vivo
- edited by Tran PV, et al. Philadelphia, PA, Lippincott Williams and Wilkins
- Olanzapine (Zyprexa): A Novel Antipsychotic , pp. 2000
- Seeman, P.¹ Kapur, S.²

23
- 0029981526
- Neuropathology of Parkinson’s disease
- (1996) J Neuropathol Exp Neurol , vol.55 , pp. 259-272
- Forno, L.S.¹

24
- 4243233709
- The effects of olanzapine on Alzheimer’s disease assessment scale scores in patients with mild to moderate Alzheimer’s disease with psychosis and behavioral disturbances
- (2000) J Am Geriatr Soc , vol.48 , pp. S111
- Kennedy, J.¹ Basson, B.² Zagar, A.³

25
- 0034598980
- Decreased binding affinity of olanzapine and clozapine for clonal human muscarinic receptor subtypes in intact CHO cells in physiological medium
- (2000) Eur J Pharmacol , vol.390 , pp. 245-248
- Bymaster, F.¹ Falcone, J.F.²

26
- 0001805637
- Management of psychosis and agitation in demented elderly with Parkinson’s disease
- (2000) Clinical Geriatrics , vol.8 , pp. 76-83
- Workman, R.H.J.¹ Stoebner, D.² Raicu, R.G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.